Notícias

CVS Health enters the second half of 2026 with stronger earnings and Aetna gains, but medical costs and Caremark risks cloud the recovery.

According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Editor’s Note: The story has been refreshed with the latest market price action. Luigi Mangione, the man accused of killing UnitedHealth Group Inc CEO Brian Thompson, is expected to plead guilty in the federal case involving Thompson’s death. Guilty Plea...

UnitedHealth misled investors, shuttered an internal Medicare billing audit and ignored cybersecurity lapses that led to the historic Change Healthcare cyberattack, according to a lawsuit filed by two shareholder groups.

Yahoo Finance Senior Columnist Kerry Hannon explains that major health insurers like Humana (HUM) and UnitedHealth Group (UNH) are dropping hundreds of thousands of Medicare Advantage members to protect profit margins as rising utilization drives up costs.

Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index decreasing 0.4% a

Luigi Mangione pleaded guilty in a federal case over the fatal shooting of UnitedHealth Group executive Brian Thompson in December 2024.

Luigi Mangione pleaded guilty to federal stalking charges related to the fatal shooting of UnitedHealth Group Inc. executive Brian Thompson. Mangione admitted on Friday in New York federal court that he shot and killed Thompson on Dec. 4, 2024. He faces life in prison. Mangione's attorney, Karen Friedman Agnifilo, US Attorney for the Southern District Jamie McDonald and NYPD Police Commissioner Jessica Tisch all spoke outside the court.

In August 2026, UnitedHealth Group’s board authorized a cash dividend of US$2.32 per share, paid on September 22, 2026, to shareholders of record as of September 14, 2026, while also outlining further exits from certain Medicare Advantage plans and updated margin expectations. These moves, alongside earnings supported by lower medical costs and a higher 2026 adjusted EPS outlook, highlight how management is reshaping its Medicare footprint and capital returns policy in response to evolving...

The 28-year-old admitted in court to killing UnitedHealthcare leader Brian Thompson, but a state murder trial still looms.

He admitted in court to killing UnitedHealthcare leader Brian Thompson, but a state murder trial still looms.

Luigi Mangione pleaded guilty to federal stalking charges related to the fatal shooting of UnitedHealth Group Inc. executive Brian Thompson. He faces a maximum sentence of life in prison. This happened in New York federal court Friday morning. Mangione also faces charges in New York state court. June Grasso of Bloomberg Law is following the breaking news on Bloomberg Radio and has more.

CVS Health is rebuilding momentum as Aetna drives stronger profits and higher 2026 guidance, but medical costs and PBM changes could test the recovery.

CVS Health advances its $20 billion technology push with AI tools, Health100 and automation aimed at simplifying care and improving engagement.

Pushed to their limits, patients are turning to social media to plead for help getting their medical care covered.

Management had named the plan exits, the Medicare margin target and the repricing date before the run began.

Management has raised its full-year earnings outlook twice, and the segment doing most of the lifting is still short of its own target margin.

HUM's HealthStream deal backs 1,000 caregiver scholarships and new tools to improve recruitment and retention in Indiana.

UnitedHealth's lower medical costs are fueling an earnings recovery, but rising commercial costs and 2027 pricing decisions could test its durability.

Mark Cuban on Monday urged investors to pressure major U.S. health insurers to address healthcare costs, calling on funds that hold shares in the industry to consider divesting their positions unless insurers change their practices. Shareholders in the Spotlight The...

Occidental Petroleum has outperformed even Berkshire's other top energy investment, but the future hinges on another crude oil price spike.

UnitedHealth's operating margin has dropped well below its own long-run level, and by the company's own account the repair in its commercial business is a multi-year job rather than a finished one.

UnitedHealth Group has outpaced the broader market over the past year, and analysts remain highly bullish about the stock’s prospects.

For years, healthcare and semiconductor stocks weren’t particularly tied to each other. In other words, they increasingly go in opposite directions: when chips sell off, healthcare has tended to catch a bid. After years of underperformance, healthcare investors are enjoying a burst of momentum amid the recent nervousness around AI.

Sen. Elizabeth Warren (D-Mass) has criticized the vertical integration in the U.S. healthcare system, arguing that it leads to higher costs for patients and increased profits for large corporations. Warren took to X on Sunday and used UnitedHealth Group Inc....

On July 29, UnitedHealth Group (NYSE:UNH) announced a $4 million commitment, funded through the United Health Foundation, to expand the University of Tennessee Health Sciences’ health hub network from 5 locations to 13 across the state by the end of 2027, a buildout expected to reach 200,000 Tennessee residents. It’s a modest sum for a […]

UnitedHealth Group (UNH) is back in focus after fresh attention on its Medicare Advantage and Optum Health businesses, which are helping offset pressure in commercial insurance and shaping how investors interpret the stock’s recent moves. See our latest analysis for UnitedHealth Group. Over the past year, UnitedHealth Group’s stock has combined a 21.01% year to date share price return with a 66.60% 1 year total shareholder return. The recent 1 month share price return of 4.13% and 7 day share...

In the health insurance arena, one company is both the undisputed leader and the most expensive ticket, forcing investors to decide if paying up for quality is a winning strategy.

Alignment Healthcare raises its 2026 outlook as membership and medical-cost trends improve, but heavier second-half investments could pressure near-term profitability.

Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improving earnings outlooks and steady sector momentum.